Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.
Puma Biotechnology will issue its 4Q and full year 2024 results on Feb. 27 and follow with a conference call at 1:30 p.m.
1d
Hosted on MSNAclaris Therapeutics Unveils Promising Data on ATI-2138, a Novel Dual ITK/JAK3 InhibitorAclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced significant findings about ATI-2138, a novel investigational drug ...
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on February 4, 2025, the Compensation ...
Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, 12850 East Montview Boulevard, Aurora, Colorado 80045, ...
Unbiased transcriptomic analysis of primary early-onset vs late-onset colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does not ...
The northern lights, or aurora borealis, have been a near-weekly occurrence in recent months. Back in May of 2024, aurora borealis lit up the skies for nearly a week straight, and in October ...
Not all types of flu are the same. Some types of flu can make you very ill, while others cause milder symptoms. Read on to learn about the different types of flu. Flu, or influenza, is a ...
Denver Public Schools, Aurora Public Schools, Poudre School District and St. Vrain Valley School District are among the districts delays school by two hours. So is Steamboat Springs School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results